September 30,2017

Press Contact:

Katie Niederee (Hatch): 202-224-4515

Taylor Harvey (Wyden): 202-224-4515

Hatch and Wyden Announce CHIP Bill Markup

Senate Finance Committee to Consider Five-Year Funding Extension for CHIP

WASHINGTON – Senate Finance Committee Chairman Orrin Hatch (R-Utah) and Ranking Member Ron Wyden (D-Ore.) announced they will hold a markup of the Keeping Kids’ Insurance Dependable and Secure (KIDS) Act (S. 1827) on Wednesday, Oct. 4, 2017. The markup will take place at 9:30 a.m. in Room 215 of the Dirksen Senate Office Building.

“This important legislation will ensure the vulnerable children and their families who depend on CHIP receive much-needed certainty by guaranteeing uninterrupted funding for the program, which has been a top priority of this committee,” Hatch said. “While all states and D.C. have funding that will continue to be available beyond today, I am looking forward to working with my colleagues to advance this bill in a fiscally responsible manner so it may be signed into law as quickly as possible to ensure coverage for kids is maintained.”

“Congress needs to act quickly to secure kids’ health care, and next week’s markup of the Senate’s strong, bipartisan CHIP bill is an important step,” Wyden said. “Every day that passes without action following the funding deadline this Saturday means more heartache for children and families and more uncertainty for states. I will be pulling out all the stops to ensure Congress keeps its promise to America’s kids.”

The Chairman’s Mark can be found here. The score of the bill can be found here.

Hatch and Wyden held a hearing The Children's Health Insurance Program: the Path Forward earlier this month and shortly after announced a bipartisan agreement to extend CHIP funding.

                Who:     Senate Finance Committee

                What:    CHIP Markup

                Where: 215 Dirksen Senate Office Building

                                Washington, D.C. 20510

                When:  Wednesday, Oct. 4, 2017 at 9:30 a.m.

For media inquiries and additional information, including webcast and testimony details, please visit: